40.58  -0.055 (-0.14%)		10-19 10:15
Open: 40.58 High: 40.58 Volume: 2,193		Pre. Close: 40.6353 Low: 40.58 Market Cap: 105(M)

Short term
Mid term
Targets	6-month :	48.37	1-year :	56.5
Resists	First :	41.41	Second :	48.37
Pivot price	39.38
Supports	First :	39.71	Second :	38.66
MAs	MA(5) :	39.91	MA(20) :	39.46
	MA(100) :	39.78	MA(250) :	37.23
MACD	MACD :	-0.2	Signal :	-0.4
%K %D	K(14,3) :	89	D(3) :	80.8
RSI	RSI(14): 60.8
52-week	High :	42.11	Low :	32.04

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SPDV ] has closed Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	40.54 - 40.74	40.74 - 40.92
Low:	39.45 - 39.68	39.68 - 39.89
Close:	40.06 - 40.41	40.41 - 40.74

ETF Series Solutions - AAM S&P 500 High Dividend Value ETF is an exchange traded fund launched by ETF Series Solutions. It is co-managed by Advisors Asset Management, Inc. and Vident Asset Management. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across diversified sectors. The fund invests in growth and value stocks of large-cap companies, within the market capitalization range of the S&P 500 Index. It invests in dividend paying stocks of companies. It seeks to track the performance of the S&P 500 Dividend and Free Cash Flow Yield Index, by using full replication technique. ETF Series Solutions - AAM S&P 500 High Dividend Value ETF was formed on November 28, 2017 and is domiciled in the United States.

Thu, 24 Sep 2026
Generic, Biosimilar Medicines Saved US Health Care $496B in 2025 - Center for Biosimilars

Thu, 20 Aug 2026
American Alliance of Museums Launches Museum Leadership Academy and Announces Inaugural Cohort - American Alliance of Museums

Wed, 22 Jul 2026
The Brazilian Eve eVTOL Is Coming to Florida’s Premier AAM Research Hub - autoevolution

Thu, 18 Jun 2026
Gresham flies back into market with AAM’s $160m poultry fund - AFR

Mon, 02 Mar 2026
Advanced Air Mobility takes shape through US regulatory initiatives -- Part 2 - Daily Journal

Tue, 03 Feb 2026
AAM rebrand to Dauch Corp. seeks global appeal as Dowlais deal closes - The Detroit News

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.